Belvedere Trading’s Bionano Genomics BNGO Stock Holding History

Belvedere Trading’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$1.78K	–	967
2022 Q4	$1.78K	Buy	+2	New	+$2.52K	﹤0.01%	1053

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Belvedere Trading's BNGO Position: Q1 2023 in Review

Belvedere Trading sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 2 shares — an estimated $1.78K sold.

Belvedere Trading first reported a position in BNGO in Q4 2022 and held it in 1 quarter. The position peaked at $1.78K in Q4 2022. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

Belvedere Trading reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
Belvedere Trading sold 2 Bionano Genomics shares in Q1 2023, an estimated $1.78K.
Belvedere Trading first reported a position in Bionano Genomics in Q4 2022 and held it in 1 quarter.
Belvedere Trading's Bionano Genomics position peaked at $1.78K in Q4 2022.
126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.